Navigation Links
SCOLR Pharma, Inc. Schedules Fourth Quarter 2008 Financial Results Conference Call for March 11, 2009 at 11:30 A.M. Eastern
Date:3/5/2009

BOTHELL, Wash., March 5 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (NYSE Alternext US: DDD) today announced plans to release fourth quarter 2008 financial results on Wednesday, March 11, 2009, at 8:30 a.m. Eastern. Dr. Bruce S. Morra, President and CEO of SCOLR Pharma, will host the conference call at 11:30 a.m. Eastern, to discuss the Company's results for the quarter.

Shareholders and other interested parties may participate in the conference call by dialing +1 888 679 8035 (domestic) or +1 617 213 4848 (international) and entering access code 70937060, a few minutes before 11:30 a.m. ET on March 11, 2009. The call will also be broadcast live on the Internet at www.streetevents.com, www.fulldisclosure.com or www.scolr.com.

A replay of the conference call will be accessible two hours after its completion through March 25, 2009, by dialing +1 888 286 8010 (domestic) or +1 617 801 6888 (international) and entering access code 66312665. The call will also be archived for 90 days at www.streetevents.com, www.fulldisclosure.com or www.scolr.com.

About SCOLR Pharma:

Based in Bothell, Washington, SCOLR Pharma, Inc. is a specialty pharmaceutical company whose objective is to combine its formulation expertise and its patented CDT platforms to develop novel prescription pharmaceutical, over-the-counter (OTC), and nutritional products. Our CDT drug delivery platforms are based on multiple issued and pending patents and other intellectual property for the programmed release or enhanced performance of active pharmaceutical ingredients and nutritional products. For more info
'/>"/>

SOURCE SCOLR Pharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. SCOLR Pharma, Inc. Announces Appointment of Bruce S. Morra, Ph.D., as President & CEO
2. SCOLR Pharma, Inc. Announces Resignation of CEO Daniel O. Wilds
3. SCOLR Pharma, Inc. Announces Positive Top-Line Results From Pivotal Clinical Trial Evaluating Efficacy of Extended-Release Ibuprofen
4. SCOLR Pharma, Inc. Schedules Third Quarter 2008 Financial Results Conference Call for November 7, 2008 at 11:30 A.M. Eastern
5. SCOLR Pharma, Inc. Submits Abbreviated New Drug Application for a 12-hour CDT-based Pseudoephedrine Formulation
6. China Biopharma, Inc. Issues Corporate Information Update
7. Why Do Drugs Cost So Much? and why are we so darn sick?: New Book Reveals Inner Workings of Big Pharma, Asks Hard Questions About Our Health
8. Galderma Pharma, S.A. and ZARS Pharma, Inc. Extend Agreement to Cover Worldwide Rights for Pliaglis(TM)
9. Legislative and Regulatory Outlook - 2009 and Beyond for Pharma, Biotech Players
10. TyRx Pharma, Inc. Announces Presentation of Results to Benefit Women with Breast Implants (In-Vivo Efficacy Study Regarding AIGISRx DEB) at the Plastic Surgery 2007 Meeting on October, 28 2007 in Baltimore, MD
11. GeoPharma, Inc. to Present at the EdgeWater Research Investor Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...N,N.J.,Nov.27/PRNewswire/--Thediabetespopulationin...ndannualmedicalspendingonthediseaseisprojectedtohi...udypublishedintheDecemberissueof DiabetesCare .The...gramofNovoNordisk,commissionedtheanalysisbyateamfr...cast,thenumberofAmericanslivingwithdiabeteswillris...
(Date:11/26/2009)...r thrill when on an emotional rollercoaster, study...News) -- Call it the fear factor meets the jubilan...ators -- especially those who root for the winning... closely contested match and victory was in doubt,..., Chew on that this Thanksgiving weekend as you,re...
(Date:11/26/2009)... Benton Communications announces a highly...em for retailers struggling to make an economic re...r 26, 2009 -- Flu fears is the type of challenge t...cy room, according to Dr. David Benton, business g...ness growth system – The Rfactor Intensive ...
(Date:11/25/2009)...LE,Calif.,Nov.25/PRNewswire-FirstCall/-- OnyxPhar...hecompanywillhosttwoinvestoreventsinDecember: ,...T/10:00a.m.ET ,, Principalinvestigatorswilldi...psedand/orrefractorymultiplemyeloma,asfeaturedatth...andExpositioninNewOrleans,LA.Theteleconferencewill...
(Date:11/25/2009)...RING,Md.,Nov.25/PRNewswire-USNewswire/--Anarticleb...gEvaluationandResearch,titled"ADifficultBalance-Pa....26,2009issueofTheNewEnglandJournalofMedicine. ,...0824/FDALOGO ) ,, Inthearticle,Woodcockdiscusse...cationforthosewhoneeditandmanagingtherisksposedbyv...
Breaking Medicine News(10 mins):Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2
...don,t know there are official treatment guidelines...rican Heart Association and the American Cancer So...rapies are the most effective and have the least a...r not. , Mesa, AZ (PRWEB)...
...and hires leading bariatric surgeon to help meet i... Toronto, ON (PRWEB), April 24, ...heir surgical team with Dr. Jamie Cyriac appointed...s credentials include completing his fellowship in...
...hanna institute of Lasik gives back to the communi...oration. , Westlake Villa... an affluent, prestigious, private high school, ne...onating several surgeries, educational books, and ...
...Research Council President Tony Perkins released ...us vetoed a pro-life bill that increases reporting...ortions and allows lawsuits against them if a pati...ius has placed the interests of late-term abortion...
...nd might be replicated for heart disease, scientis...News) -- The successful use of a patient,s own ski...sis could portend a revolution in kidney care, res... creates a shunt -- a connection between the patie...
...rtland Dental Care, Inc. acquired six dental pract...ing first quarter 2009. , , The six acquisitions ...., Las Vegas, Nev., Phoenix, Ariz., Glendale, Ariz...the total number of Heartland Dental Care practice...
Other Medicine News:Health News:An Innovative New Book Helps Consumers Find Out if Their Doctors are Following Official Treatment Guidelines 2Health News:Slimband Expands Surgical Team and Appoints New Surgeon Dr. Jamie Cyriac (MD, FRCS (C), FACS) 2Health News:Khanna Institute Supports Oaks Christian School's Annual Fundraiser 2Health News:Sebelius Places Interests of Late-Term Abortionists Ahead of Unborn Children 2Health News:First Vessel Graft Grown From Kidney Patients' Own Cells 2Health News:First Vessel Graft Grown From Kidney Patients' Own Cells 3Health News:First Vessel Graft Grown From Kidney Patients' Own Cells 4Health News:Heartland Dental Care, Inc. Adds Eight Dental Practices In First Quarter 2009 2
(Date:11/25/2009)...ResearchGroup,Inc.releasedWave1ofits LaunchTrends...dicatedmarketresearchprojecttrackingthelaunchofCen...ghthefirstsixmonthsofavailability.Eachwaveoftherep...atologistsandqualitativeinformationfromasubsetof20...se,typicalpatienttypes,productperceptions,promotio...
(Date:11/25/2009)...rstCall/--FormanyofthemillionsofhearingimpairedAme...earingloss ,theholidaysmaynotbeallthathappy,saysau...identofHearUSA(Amex: EAR ),oneofAmerica,slargesthe...linkedhearinglosstostress,frustration,andsocialiso...ingswithfamiliesandfriends,whenmanyofthosewithhear...
(Date:11/25/2009)...--AMPACFineChemicalsLLC(AFC),asubsidiaryofAmerican...titreceivedtheEnvironmentalResponsibilityandSustai...it,sponsoredbytheCaliforniaManufacturersandTechnol...ociation(IEA)andtheChemicalIndustryCouncilofCalifo...wardavailablefromallthreeorganizationsandgainssubs...
Breaking Medicine Technology:Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2Exosome Diagnostics Appoints Former Roche Executive Greg Zdechlik as Chief Operating Officer 13167 1Exosome Diagnostics Appoints Former Roche Executive Greg Zdechlik as Chief Operating Officer 13167 2U S Fund for UNICEF and Jenna Bush Hager Announce Next Generation Initiative to Improve Lives of Children Around the World 52532 1U S Fund for UNICEF and Jenna Bush Hager Announce Next Generation Initiative to Improve Lives of Children Around the World 52532 2Rising Medical Solutions Inc Launches Unified Healthcare Portal for Payers Patients and Providers 52530 1Rising Medical Solutions Inc Launches Unified Healthcare Portal for Payers Patients and Providers 52530 2Rising Medical Solutions Inc Launches Unified Healthcare Portal for Payers Patients and Providers 52530 3
...4, 2007 – Data presented,today at this year&...O) meeting in Chicago show that a novel combinatio...ouracil (5-FU) therapy UFT,(tegafur–uracil) ...se rate in the first-line treatment of metastatic ...udy of CPT-11 with Oxaliplatin combined,with UFT p...
... After Sleep Onset and Total,Sleep Time, and key s...t Sleep, were met at both doses - Evotec to host a...) today , HAMBURG, Germany | OXFORD, England, June...T) announced today positive top-line,results from ...tients with chronic primary insomnia. EVT 201 is a...
Other Medicine Technology:Merck at ASCO 2007: New Data Demonstrate the Value of UFT as an,Important Treatment Option for Patients With Metastatic Colorectal,Cancer 2Merck at ASCO 2007: New Data Demonstrate the Value of UFT as an,Important Treatment Option for Patients With Metastatic Colorectal,Cancer 3Evotec AG (DE) - Evotec Reports Positive Proof-of-Concept Top-Line,Results with ... 2Evotec AG (DE) - Evotec Reports Positive Proof-of-Concept Top-Line,Results with ... 3Evotec AG (DE) - Evotec Reports Positive Proof-of-Concept Top-Line,Results with ... 4
...roducing pancreatic beta cells generally occurs ov...of overt diabetes mellitus. During this extended p...of autoantibodies against a variety of islet cell ...D65), IA-2 (a tyrosine phosphatase-like protein), ...
Vertical Laminar Flow Work Station
HERAsafe HS12
Bench Top Class I Containment Cabinet Personnel Protection
Medicine Products: